AI is about to change healthcare. These 43 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Intapp, you need to believe its vertical focus and AI-led cloud platform, especially Celeste, can justify ongoing investment despite sustained losses. The key near term catalyst remains whether Celeste and cloud ARR can convert strong interest into durable, high quality recurring revenue. The biggest risk, in my view, is that rising AI and cloud spend does not translate into enough differentiation to improve margins. The latest results, with higher losses, make this risk feel more immediate.
The most relevant recent announcement here is Intapp’s fiscal 2027 revenue guidance of US$528.7 million to US$532.7 million, which sits below the US$577.81 million it reported for 2026. Set against rapid enterprise uptake of Celeste and doubling AI bookings, that guide may temper expectations for a quick payoff from AI investments, putting extra focus on how effectively Intapp can convert early Celeste enthusiasm into profitable, recurring cloud growth.
Yet while AI adoption is clearly accelerating, investors should be aware that Intapp’s rising losses and slower guided revenue still leave open the possibility that...
Read the full narrative on Intapp (it's free!)
Intapp's narrative projects $912.0 million revenue and $88.7 million earnings by 2029. This requires 16.4% yearly revenue growth and a $130.0 million earnings increase from -$41.3 million today.
Uncover how Intapp's forecasts yield a $39.43 fair value, in line with its current price.
Some of the lowest ranked analysts were assuming revenue of about US$821.9 million and only US$5.8 million of earnings by 2029, which is far more cautious than the consensus and could look very different in light of Celeste’s rapid uptake and Intapp’s new 2027 guidance.
Explore 5 other fair value estimates on Intapp - why the stock might be worth as much as 53% more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com